Bioventus Inc (BVS)
11.75
+0.08
(+0.69%)
USD |
NASDAQ |
Oct 04, 16:00
11.75
0.00 (0.00%)
After-Hours: 20:00
Bioventus Shareholders Equity (Annual): 173.59M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 173.59M |
| December 31, 2022 | 325.24M |
| December 31, 2021 | 458.92M |
| December 31, 2020 | 144.16M |
| Date | Value |
|---|---|
| December 31, 2019 | 142.98M |
| December 31, 2018 | 145.27M |
| December 31, 2015 | 192.34M |
| December 31, 2014 | 177.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
142.98M
Minimum
2019
458.92M
Maximum
2021
248.98M
Average
173.59M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Retractable Technologies Inc | 99.29M |
| InfuSystems Holdings Inc | 52.30M |
| Xtant Medical Holdings Inc | 51.35M |
| Catheter Precision Inc | 21.19M |